menu
    • menu

    Company profile for Cellworks

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cellworks is a world leader in Personalized Medicine in the key therapeutic areas of Oncology and Immunology. Using innovative multi-omics modeling, computational biosimulation and Artificial Intelligence heuristics, Cellworks predicts the most efficacious therapies for patients. The Cellworks unique biosimulation platform is a unified representation of biological knowledge curated from heterogeneous datasets and applied to fi...
    Cellworks is a world leader in Personalized Medicine in the key therapeutic areas of Oncology and Immunology. Using innovative multi-omics modeling, computational biosimulation and Artificial Intelligence heuristics, Cellworks predicts the most efficacious therapies for patients. The Cellworks unique biosimulation platform is a unified representation of biological knowledge curated from heterogeneous datasets and applied to finding cures. Backed by UnitedHealth Group, Sequoia Capital, Agilent and Artiman, Cellworks has the world’s strongest trans-disciplinary team of molecular biologists, cellular pathway modelers and software technologists

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CellworksUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Oyster Point Blvd, Suite 207, South San Francisco, CA - 94080
    Telephone
    Telephone
    +1 650 418 3804
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cellworks.life/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cellworks-life/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cellworkslife

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cellworks Reveals Chemo-IO Benefit Prediction in Metastatic NSCLC
    Cellworks Reveals Chemo-IO Benefit Prediction in Metastatic NSCLC

    08 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250908286080/en/Cellworks-Unveils-a-Breakthrough-in-Predicting-Chemo-Immunotherapy-Benefit-for-Patients-with-Metastatic-NSCLC

    BUSINESSWIRE
    08 Sep 2025
    Share Share
    Cellworks Study Predicts NSCLC Patient Immunotherapy Response
    Cellworks Study Predicts NSCLC Patient Immunotherapy Response

    08 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250908354231/en/Cellworks-Study-Reveals-Tumor-Microenvironment-and-TLS-Dynamics-Together-Predict-Patient-Level-Immunotherapy-Response-in-NSCLC

    BUSINESSWIRE
    08 Sep 2025
    Share Share
    Cellworks Study Predicts Immune Checkpoint Inhibitor Resistance
    Cellworks Study Predicts Immune Checkpoint Inhibitor Resistance

    29 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250429658932/en/Cellworks-Study-Predicts-Immune-Checkpoint-Inhibitor-Resistance-in-Patients-with-High-Microsatellite-Instability

    BUSINESSWIRE
    29 Apr 2025
    Share Share
    Cellworks Enhances TRI for NSCLC Immunotherapy Survival Prediction
    Cellworks Enhances TRI for NSCLC Immunotherapy Survival Prediction

    12 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241112097624/en

    BUSINESSWIRE
    12 Nov 2024
    Share Share
    Cellworks Biosimulation Predicts PARPi Benefit In Multiple Cancers
    Cellworks Biosimulation Predicts PARPi Benefit In Multiple Cancers

    16 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240916301028/en

    BUSINESSWIRE
    16 Sep 2024
    Share Share
    Cellworks Biosimulation Enhances IO Response Predictions In NSCLC
    Cellworks Biosimulation Enhances IO Response Predictions In NSCLC

    16 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240916503328/en

    BUSINESSWIRE
    16 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search